Merrill Lynch recommends buying Reliance Infra with a target of Rs 1,081, the stock is currently trading at Rs 540. They see positives from the bottoming of Mumbai license area profits, a pick-up in execution and growth across the power, roads and metro rail domains.
Credit Suisse has an outperform stance with a target of Rs 480 onLupin . The company is working on eight products and is planning to launch its first biosimilar in India in FY12. The two most advanced products are about to commence clinical trials.